Using measures to guide the continuous improvement journey: a partnership between quality assurance and toxicology.
It has been said that you cannot improve what you cannot measure. At Eli Lilly and Company, measurement is one of the five pillars of Total Quality. Quality Assurance and Toxicology have partnered in the use of measures to drive improvements in both areas. Quality Assurance and Toxicology have embarked on a journey in Total Quality to achieve customer satisfaction and drive continuous improvement. Measurement in the research and development world has traditionally not been well received. Contrary to popular belief, we have found that many processes can be measured in the research and development environment. Measurement is critical to the continuous improvement of processes because improvements are made using data. In Quality Assurance and Toxicology, the initial measures were put in place to gather baseline data. As we learned from our measures, we customized them to align with all of our processes. This article describes the journey of measuring Quality Assurance and Toxicology, including highlights of implementation strategies and lessons learned along the way.
Gentry
P E
PE
Eli Lilly and Company, Toxicology Division and Quality Assurance, Greenfield, Indiana 46140.
Sites
D L
DL
D003142:Communication; D003258:Consumer Behavior; D003625:Data Collection / Q000379:methods*; D004345:Drug Industry; D007373:Interinstitutional Relations; D009936:Organizational Innovation; D012016:Reference Values; D013192:Staff Development / Q000379:methods*; D017749:Total Quality Management / Q000379:methods*; D014116:Toxicology / Q000592:standards*